• 제목/요약/키워드: Cancer symptoms

검색결과 1,232건 처리시간 0.032초

Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis

  • Parisima Ghaffarian Zavarzadeh;Zahra Abedi
    • Genomics & Informatics
    • /
    • 제21권1호
    • /
    • pp.6.1-6.8
    • /
    • 2023
  • Glaucoma is the second leading cause of irreversible blindness, and primary open-angle glaucoma (POAG) is the most common type. Due to inadequate diagnosis, treatment is often not administered until symptoms occur. Hence, approaches enabling earlier prediction or diagnosis of POAG are necessary. We aimed to identify novel drugs for glaucoma through bioinformatics and network analysis. Data from 36 samples, obtained from the trabecular meshwork of healthy individuals and patients with POAG, were acquired from a dataset. Next, differentially expressed genes (DEGs) were identified to construct a protein-protein interaction (PPI) network. In both stages, the genes were enriched by studying the critical biological processes and pathways related to POAG. Finally, a drug-gene network was constructed, and novel drugs for POAG treatment were proposed. Genes with p < 0.01 and |log fold change| > 0.3 (1,350 genes) were considered DEGs and utilized to construct a PPI network. Enrichment analysis yielded several key pathways that were upregulated or downregulated. For example, extracellular matrix organization, the immune system, neutrophil degranulation, and cytokine signaling were upregulated among immune pathways, while signal transduction, the immune system, extracellular matrix organization, and receptor tyrosine kinase signaling were downregulated. Finally, novel drugs including metformin hydrochloride, ixazomib citrate, and cisplatin warrant further analysis of their potential roles in POAG treatment. The candidate drugs identified in this computational analysis require in vitro and in vivo validation to confirm their effectiveness in POAG treatment. This may pave the way for understanding life-threatening disorders such as cancer.

Use of cutting-edge RNA-sequencing technology to identify biomarkers and potential therapeutic targets in canine and feline cancers and other diseases

  • Youngdong Choi;Min-Woo Nam;Hong Kyu Lee;Kyung-Chul Choi
    • Journal of Veterinary Science
    • /
    • 제24권5호
    • /
    • pp.71.1-71.12
    • /
    • 2023
  • With the growing interest in companion animals and the rapidly expanding animal healthcare and pharmaceuticals market worldwide. With the advancements in RNAsequencing (RNA-seq) technology, it has become a valuable tool for understanding biological processes in companion animals and has multiple applications in animal healthcare. Historically, veterinary diagnoses and treatments relied solely on clinical symptoms and drugs used in human diseases. However, RNA-seq has emerged as an effective technology for studying companion animals, providing insights into their genetic information. The sequencing technology has revealed that not only messenger RNAs (mRNAs) but also noncoding RNAs (ncRNAs) such as long ncRNAs and microRNAs can serve as biomarkers. Based on the examination of RNA-seq applications in veterinary medicine, particularly in dogs and cats, this review concludes that RNA-seq has significant potential as a diagnostic and research tool. It has enabled the identification of potential biomarkers for cancer and other diseases in companion animals. Further research and development are required to maximize the utilization of RNA-seq for improved disease diagnosis and therapeutic targeting in companion animals.

한국 한의서를 중심으로 살펴본 '비훈(鼻熏)요법'의 활용에 대한 연구 (A Study on the Use of Bihoon (鼻熏) Therapy, which focuses on Korean traditional medicine)

  • 김동율;이지영
    • 한국의사학회지
    • /
    • 제36권2호
    • /
    • pp.99-113
    • /
    • 2023
  • This paper is a study to find the philological basis of Bihoon (鼻熏) therapy. There is no separate philological study of Bihoon therapy to date, and for this reason, there is no clear definition or specific treatment manual. In this study, a related database was created and analyzed by examining literature data related to Bihoon therapy, focusing on Korean traditional medical books. There were about 1,000 data points related to Bihoon therapy in 45 kinds of medical books. They were largely classified into 1. Acute diseases such as insensitivity, 2. Diseases that occur in the upper human body such as nose, head, eyes, and throat, 3. Women's diseases related to childbirth, 4. Treatment of skin diseases and prevention of infectious diseases. In the case of insensitivity treatment, the focus was on awakening the patient's mind, and the treatment of diseases such as the nose, head, eyes, etc. was focused on resolving each symptom. Symptoms related to childbirth were mainly treated for uterine escapism or fainting after childbirth, while skin diseases were mainly treated for diseases that did not heal well, such as amniotic fluid. If a multifaceted approach to non-discipline therapy is added in the future, it is expected that clinical utilization will also be increased.

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

  • Juwhan Choi;Sung Yong Lee
    • IMMUNE NETWORK
    • /
    • 제20권1호
    • /
    • pp.9.1-9.21
    • /
    • 2020
  • Immune checkpoint inhibitors (ICIs) have been changing the paradigm of cancer treatment. However, immune-related adverse effects (irAEs) have also increased with the exponential increase in the use of ICIs. ICIs can break up the immunologic homeostasis and reduce T-cell tolerance. Therefore, inhibition of immune checkpoint can lead to the activation of autoreactive T-cells, resulting in various irAEs similar to autoimmune diseases. Gastrointestinal toxicity, endocrine toxicity, and dermatologic toxicity are common side effects. Neurotoxicity, cardiotoxicity, and pulmonary toxicity are relatively rare but can be fatal. ICI-related gastrointestinal toxicity, dermatologic toxicity, and hypophysitis are more common with anti- CTLA-4 agents. ICI-related pulmonary toxicity, thyroid dysfunction, and myasthenia gravis are more common with PD-1/PD-L1 inhibitors. Treatment with systemic steroids is the principal strategy against irAEs. The use of immune-modulatory agents should be considered in case of no response to the steroid therapy. Treatment under the supervision of multidisciplinary specialists is also essential, because the symptoms and treatments of irAEs could involve many organs. Thus, this review focuses on the mechanism, clinical presentation, incidence, and treatment of various irAEs.

Beyond the mouth: Uncovering non-secretory multiple myeloma through oral symptoms

  • Pedro Henrique Chaves Isaias;Fabio Wildson Gurgel Costa;Pedro Henrique Goncalves Holanda Amorim;Raul Anderson Domingues Alves da Silva;Fabrício Bitu Sousa;Karuza Maria Alves Pereira;Ana Paula Negreiros Nunes Alves;Mario Rogério Lima Mota
    • Imaging Science in Dentistry
    • /
    • 제54권2호
    • /
    • pp.211-220
    • /
    • 2024
  • Non-secretory multiple myeloma (NSMM) is a rare cancer of plasma cells characterized by the absence of detectable monoclonal M protein in the blood or urine. A 57-year-old woman presented with mandibular pain but without intraoral swelling. Imaging studies revealed multiple osteolytic lesions in her mandible and pronounced root resorption of the left mandibular second molar. Biopsy results showed atypical plasmacytoid cells positive for anti-kappa, CD138, MUM1, and CD79a antibodies, but negative for anti-lambda and CD20. These results were indicative of a malignant plasma cell neoplasm. No abnormalities were revealed by free light chain assay or by serum or urine protein electrophoresis, leading to a diagnosis of NSMM. The patient began chemotherapy in conjunction with bisphosphonate therapy and achieved remission following treatment. This case underscores the critical role of dentists in the early detection and prevention of NSMM complications, as the disease can initially present in the oral cavity.

End-of-Life Care for End-stage Heart Failure Patients

  • Ju-Hee Lee;Kyung-Kuk Hwang
    • Korean Circulation Journal
    • /
    • 제52권9호
    • /
    • pp.659-679
    • /
    • 2022
  • Efforts to improve end-of-life (EOL) care have generally been focused on cancer patients, but high-quality EOL care is also important for patients with other serious medical illnesses including heart failure (HF). Recent HF guidelines offer more clinical considerations for palliative care including EOL care than ever before. Because HF patients can experience rapid, unexpected clinical deterioration or sudden death throughout the disease trajectory, choosing an appropriate time to discuss issues such as advance directives or hospice can be challenging in real clinical situations. Therefore, EOL issues should be discussed early. Conversations are important for understanding patient and family expectations and developing mutually agreed goals of care. In particular, high-quality communication with patient and family through a multidisciplinary team is necessary to define patient-centered goals of care and establish treatment based on goals. Control of symptoms such as dyspnea, pain, anxiety/depression, fatigue, nausea, anorexia, and altered mental status throughout the dying process is an important issue that is often overlooked. When quality-of-life outweighs expanding quantity-of-life, the transition to EOL care should be considered. Advanced care planning including resuscitation (i.e., do-not resuscitate order), device deactivation, site for last days and bereavement support for the family should focus on ensuring a good death and be reviewed regularly. It is essential to ensure that treatment for all HF patients incorporates discussions about the overall goals of care and individual patient preferences at both the EOL and sudden changes in health status. In this review, we focus on EOL care for end-stage HF patients.

Radiation Proctitis and Management Strategies

  • Dushyant Singh Dahiya;Asim Kichloo;Faiz Tuma;Michael Albosta;Farah Wani
    • Clinical Endoscopy
    • /
    • 제55권1호
    • /
    • pp.22-32
    • /
    • 2022
  • Radiotherapy (RT) is a treatment modality that uses high-energy rays or radioactive agents to generate ionizing radiation against rapidly dividing cells. The main objective of using radiation in cancer therapy is to impair or halt the division of the tumor cells. Over the past few decades, advancements in technology, the introduction of newer methods of RT, and a better understanding of the pathophysiology of cancers have enabled physicians to deliver doses of radiation that match the exact dimensions of the tumor for greater efficacy, with minimal exposure of the surrounding tissues. However, RT has numerous complications, the most common being radiation proctitis (RP). It is characterized by damage to the rectal epithelium by secondary ionizing radiation. Based on the onset of signs and symptoms, post-radiotherapy RP can be classified as acute or chronic, each with varying levels of severity and complication rates. The treatment options available for RP are limited, with most of the data on treatment available from case reports or small studies. Here, we describe the types of RT used in modern-day medicine and radiation-mediated tissue injury. We have primarily focused on the classification, epidemiology, pathogenesis, clinical features, treatment strategies, complications, and prognosis of RP.

식도암 환자의 GET 영상 평가 (GET Imaging Evaluation of Patients with Esophageal Cancer)

  • 문종운;이충운;서영덕;윤상혁;김용근;원우재
    • 핵의학기술
    • /
    • 제17권2호
    • /
    • pp.31-36
    • /
    • 2013
  • 위배출 시간 측정(Gastric Emptying Time, GET)은 비침습적이고 정량적 평가 방법으로서 주로 내시경이나 방사선적 검사로 기계적 폐쇄가 없음이 확인된 위정체 증상을 보이는 환자를 검사한다. 이와 같은 일반적인 위배출 시간 측정 검사 외에 식도암 환자(식도 절제술을 시행한)를 대상으로 수술 직후와 1년 이상의 시간이 지난 후의 위배출 시간 측정 검사를 시행하여, 수술 후 흉강내에서 위장 기능의 평가 자료로서 위배출 시간 측정 검사의 유용성을 평가하고자 한다. 본원을 내원해서 식도 절제술을 시행한 환자 93명을 대상으로 위배출 시간 측정 검사를 수술 직후와 1년 이상의 시간이 지난 후에 두 번 시행하였다. 환자의 검사 전 준비사항으로는 12시간 이상 밤새 공복과 약재나 흡연을 중단 시켜야 하고 당뇨병 환자는 인슐린 주사 후 아침 일찍 검사하는 것이 이상적이다. 검사 방법은 유동식의 위배출 시간 측정은 예민도가 떨어지므로 시행하지 않고, 고형식의 위배출 시간 측정 방법으로 $^{99m}Tc-DTPA$로 표지된 레진이 들어간 계란찜, 그리고 김밥과 점성이 높은 발효유와 함께 먹은 후 입위 자세로 3시간 동안 측정하였다. 검사의 평가 방법은 위배출 곡선 상에서 위내 방사능치가 50%가 되는 시간, 즉 반감기(T1/2)를 구하였고, 반감기가 180분 이상시 지연 위배출, 180분 이내는 중등도, 삼킴과 동시에 소장으로 넘어가는 경우를 급속 위배출로 구분하였다. 일반적인 위배출 시간 측정 영상은 위의 전정부와 위저부가 강하게 나타나는 영상에서 시간이 지남에 따라 소장으로 넘어가는 영상이지만, 식도 절제술을 시행한 식도암 환자는 흉강쪽에 강한 집적 영상을 보였다. 수술 직후 반감기(T1/2)는 급속 위배출이 12.9%, 중등도 위배출이 52.7%, 지연 위배출이 34.4%로 나타났다. 이후 1년 이상의 시간이 흐른 뒤의 반감기 결과는 수술 직후 급속 위배출 환자 중 67%가 중등도 위배출로, 지연 위배출을 보였던 환자는 69%가 중등도 위배출로 나타났다. 중등도 위배출을 보였던 환자 중 급속 위배출 이나 지연 위배출로 나빠진 경우는 24%이다. 식도 절제술을 시행한 식도암 환자의 위배출 시간 측정 검사는 반감기(T1/2)가 급속 위배출 및 지연 위배출에서 시간이 지날수록 중등도 위배출로 변하는 소견을 보였다. 이는 주로 위를 보는 위배출 시간 측정 검사가 흉강내의 식도를 대신하는 위장 기능의 평가에도 유용하게 쓰일 수 있다는 것을 의미한다. 그리고 평가 기준을 세분화하고 검사의 시간 간격을 좁힌다면 좀 더 많은 정보와 분석으로 정확한 임상 진단과 평가가 이루어질 것으로 보인다.

  • PDF

암환자를 위한 호스피스 케어에 관한 탐색적 연구 (An Exploratory Study of Hospice Care to Patients with Advanced Cancer)

  • 박혜자
    • 대한간호
    • /
    • 제28권3호
    • /
    • pp.52-67
    • /
    • 1989
  • True nursing care means total nursing care which includes physical, emotional and spiritual care. The modern nursing care has tendency to focus toward physical care and needs attention toward emotional and spiritual care. The total nursing care is mandatory for patients with terminal cancer and for this purpose, hospice care became emerged. Hospice case originated from the place or shelter for the travellers to Jerusalem in medieval stage. However, the meaning of modem hospice care became changed to total nursing care for dying patients. Modern hospice care has been developed in England, and spreaded to U.S.A. and Canada for the patients with terminal cancer. Nowaday, it became a part of nursing care and the concept of hospice care extended to the palliative care of the cancer patients. Recently, it was introduced to Korea and received attention as model of total nursing care. This study was attempted to assess the efficacy of hospice care. The purpose of this study was to prove a difference in terms of physical, emotional a d spiritual aspect between the group who received hospice care and who didn't receive hospice care. The subject for this study were 113 patients with advanced cancer who were hospitalized in the S different hospitals. 67 patients received hospice care in 4 different hospitals, and 46 patients didn't receive hospice care in another 4 different hospitals. The method of this study was the questionaire which was made through the descriptive study. The descriptive study was made by individual contact with 102 patients cf advanced cancer for 9 months period. The measurement tool for questionaire was made by author through the descriptive study, and included the personal religious orientation obtained from chung(originated R. Fleck) and 5 emotional stages before dying from Kubler Ross. The content ol questionaire consisted in 67 items which included 11 for general characteristics, 10 for related condition with cancer, 13 for wishes far physical therapy, 13 for emotional reactions and 20 for personal religious orientation. Data for this study was collected from Aug. 25 to Oct. 6 by author and 4 other nurse's who received education and training by author for the collection of data. The collected data were ana lysed using descriptive statistics, $X^2-test$, t-test and pearson correlation coefficient. Results of the study were as follows: "H.C Group" means the group of patient with cancer who received hospice care. "Non H.C Group" means the group of patient with cancer who did not receive hospice care. 1. There is a difference between H.C Group and Non H.C Group in term of the number of physical symptoms, subjective degree of pain sensation and pain control, subjective beliefs in physical cure, emotional reaction, help of present emotional and spiritual care from other personal, needs of emotional and spiritual care in future, selection of treatment method by patients and personal religious orientation. 2. The comparison of H.C Group and Non H.C Group 1) There is no difference in wishes for physical therapy between two groups(p=.522). Among Non H.C Group, a group, who didn't receive traditional therapy and herb medicine was higher than a group who received these in degree of belief that the traditional therapy and herb medicine can cure their disease, and this result was higher in comparison to H.C Group(p=.025, p=.050). 2) Non H.C Group was higher than H.C Group in degree of emotional reaction(p=.050). H.C Group was higher than Non H.C Group in denial and acceptant stage among 5 different emotional stages before dying described by Kubler Ross, especially among the patient who had disease more than 13 months(p=.0069, p=.0198). 3) Non H.C Group was higher than H. C Group in demanding more emotional and spiritual care to doctor, nurse, family and pastor(p=. 010). 4) Non H.C Group was higher than H.C Group in demanding more emotional and spiritual care to each individual of doctor, nurse and family (p=.0110, p=.0029, P=. 0053). 5) H.C Group was higher th2.n Non H.C Group in degree of intrinsic behavior orientation and intrinsic belief orientation of personal religious orientation(p=.034, p=.026). 6) In H.C Group and Non H.C Group, the degree of emotional demanding of christians was significantly higher than non christians to doctor, nurse, family and pastor(p=. 000, p=.035). 7) In H.C Group there were significant positive correlations as following; (1) Between the degree of emotional demandings to doctor, nurse, family & pastor and: the degree of intrinsic behavior orientation in personal religious orientation(r=. 5512, p=.000). (2) Between the degree of emotional demandings to doctor, nurse. family & pastor and the degree of intrinsic belief orientation in personal religious orientation(r=.4795, p=.000). (3) Between the degree of intrinsic behavior orientation and the degree of intrinsic: belief orientation in personal religious orientation(r=.8986, p=.000). (4) Between the degree of extrinsic religious orientation and the degree of consensus religious orientation in personal religious orientation (r=. 2640, p=.015). In H.C. Group there were significant negative correlations as following; (1) Between the degree of intrinsic behavior orientation and extrinsic religious orientation in personal religious orientation (r=-.4218, p=.000). (2) Between the degree or intrinsic behavior orientation and consensus religious orientation in personal religious orientation(r=-. 4597, p=.000). (3) Between the degree of intrinsic belief orientations and the degree of extrinsic religious orientation in personal religious orientation(r=-.4388, p=.000). (4) Between the degree of intrinsic belief orientation and the degree of consensus religious orientation in personal religious orientation(r=-. 5424, p=.000). 8) In Non H.C Group there were significant positive correlation as following; (1) Between the degree of emotional demandings to doctor, nurse, family & pastor and the degree of intrinsic behavior orientation in personal religious orientation(r= .3566, p=.007). (2) Between the degree of emotional demandings to doctor, nurse, family & pastor and the degree of intrinsic belief orientation in personal religious orientation(r=.3430, p=.010). (3) Between the degree of intrinsic behavior orientation and the degree of intrinsic belief orientation in personal religious orientation(r=.9723, p=.000). In Non H.C Group there were significant negative correlation as following; (1) Between the degree of emotional demandings to doctor, nurse, family & pastor and the degree of extrinsic religious orientation in personal religious orientation(r= -.2862, p=.027). (2) Between the degree of intrinsic behavior orientation and the degree of extrinsic religious orientation in personal religious orientation(r=-. 5083, p=.000). (3) Between the degree of intrinsic belief orientation and the degree of extrinsic religious orientation in personal religious orientation(r=-. 5013, p=.000). In conclusion above datas suggest that hospice care provide effective total nursing care for the patients with terminal cancer, and hospice care is mandatory in all medical institutions.

  • PDF

소아암 환자에서 발생한 막창자염(typhlitis)의 치료성적 (Outcome of typhlitis in children with cancer)

  • 이재민;최광해;하정옥
    • Clinical and Experimental Pediatrics
    • /
    • 제51권2호
    • /
    • pp.156-161
    • /
    • 2008
  • 목 적 : 막창자염은 면역기능이 저하되고 호중구가 감소된 소아암 환자에서 호발하는 괴사성 장염으로 사망률이 매우 높은 것으로 알려져 있다. 저자들은 항암치료 중 발생한 막창자염에 대하여 적극적인 내과적 치료와 항생제 치료를 시행하여 그 치료성적을 분석하고자 본 연구를 시행하였다. 방 법 : 2002년 8월부터 2007년 7월까지 영남대학교병원 소아과에 입원하여 항암화학요법을 받은 소아암 환자 207명 중 막창자염으로 진단받은 12명을 대상으로 의무기록을 분석하였다. 진단은 임상증상과 신체검진소견, 복부단순촬영검사, 복부초음파검사와 복부전산화단층촬영으로 하였다. 항암화학요법 시행 후 증상 발생일, 백혈구수, 절대호중구수, 치료항생제의 종류 및 치료기간과 치료결과를 분석하였다. 결 과 : 막창자염으로 임상적 진단을 받은 환자는 12명(5.7%)이었으며, 임상증상은 복부통증 및 압통 12명(100%), 발열 12명(100%), 설사 9명(75%), 구토 5명(41%), 반발압통 3명(25%) 등이었다. 항암화학요법 종료일로부터 증상 발생일까지의 기간의 중앙값은 12일(범위 3-18일)이었다. 백혈구수의 중앙값은 340 / L$(30-1,270/{\mu}L)$이었으며, 절대호중구수의 중앙값은 $116/{\mu}L(0-648/{\mu}L$)이었다. 치료는 항생제 요법과 충분한 수분 공급 및 장의 휴식 등 보존적 요법을 시행하였으며 환자 12명 모두 증상이 호전되었고, 수술적 치료를 받은 경우는 없었다. 항생제 조합의 선택에 따른 항생제 사용기간의 통계적인 차이는 없었다(P=0.74). 결 론 : 항암화학요법을 받는 소아암 환자에서 발열, 우하복부 압통, 호중구감소증이 있을 때는 막창자염을 의심하여야 하며, 조기진단 및 적극적인 내과적 치료와 항생제 요법을 시행하여 좋은 결과를 얻을 수 있다고 생각된다.